Showing results (41-50 of 156) with videos related to
Sort By:
Pageof 16
European Radiology|January 16, 2026
Optimizing prostate cancer treatment with MR-guided focused ultrasound: the role of expanded ablation-to-lesion volume ratioRachelle R Bitton, Emily Vertosick, Yash Khandwala, et al.The Journal of Urology|April 2, 2017
An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate BiopsyMichael A Liss, Behfar Ehdaie, Stacy Loeb, et al.Applied Clinical Informatics|April 10, 2024
A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot StudySigrid V Carlsson, Mark A Preston, Andrew Vickers, et al.European Urology Oncology|September 26, 2022
Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic ReviewDaryl Thompson, Jonathan G Bensley, Jake Tempo, et al.European Journal of Cancer Care|September 22, 2022
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancerMegan McIntosh, Melissa J Opozda, Camille E Short, et al.BJU International|September 20, 2015
Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillanceBehfar Ehdaie, Bing Ying Poon, Daniel D Sjoberg, et al.Current Opinion in Urology|March 19, 2014
What is still needed to make focal therapy an accepted segment of standard therapy?Willemien van den Bos, Berrend G Muller, Behfar Ehdaie, et al.World Journal of Urology|June 14, 2019
Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsyPedro Recabal, Taehyoung Lee, Emily Vertosick, et al.Urologic Oncology|October 17, 2017
Concordance between patient-reported and physician-reported sexual function after radical prostatectomyAlan E Thong, Bing Ying Poon, Justin K Lee, et al.Urology Practice|August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic EfficacyJonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.Pageof 16